Tumour immunology: Cell cycle inhibitors boost tumour immunogenicity

Nature Reviews Immunology 17, 529 (2017). doi:10.1038/nri.2017.104 Author: Kirsty Minton Cyclin-dependent kinase inhibitors promote tumour regression by increasing antigen presentation and decreasing immune regulation.
Source: Nature Reviews Immunology - Category: Allergy & Immunology Authors: Tags: Research Highlight Source Type: research